Variables | Before matching | P value | After matching | P value | ||
---|---|---|---|---|---|---|
TLTG (n = 223) | LATG (n = 114) | TLTG (n = 213) | LATG (n = 111) | |||
Age (years) | 61.6 ± 11.1 | 59.5 ± 11.0 | 0.090 | 61.4 ± 10.7 | 59.8 ± 10.7 | 0.203 |
Sex | Â | Â | 0.200 | Â | Â | 0.297 |
 Male | 166 (74.4) | 77 (67.5) |  | 158 (74.2) | 76 (68.5) |  |
 Female | 57 (25.6) | 37 (32.5) |  | 55 (25.8) | 35 (31.5) |  |
Body mass index (kg/m2) | 24.2 ± 2.9 | 24.1 ± 3.3 | 0.960 | 24.2 ± 2.9 | 24.1 ± 3.3 | 0.665 |
Underlying disease | ||||||
 Cerebrovascular disease | 11 (4.9) | 8 (7.0) | 0.459 | 10 (4.7) | 8 (7.2) | 0.444 |
 Dementia | 1 (0.4) | 0 (0) | 0.474 | 1 (0.5) | 0 (0) | 0.470 |
 Congestive (Ischemic) heart disease | 20 (9.0) | 4 (3.5) | 0.075 | 19 (8.9) | 4 (3.6) | 0.109 |
 Peripheral vascular disease | 1 (0.4) | 1 (0.9) | 0.628 | 0 (0) | 1 (0.9) | 0.343 |
 Hypertension | 87 (39.0) | 41 (36.0) | 0.636 | 81 (38.0) | 41 (36.9) | 0.904 |
 Pulmonary disease | 13 (5.8) | 4 (3.5) | 0.439 | 13 (6.1) | 4 (3.6) | 0.436 |
 Diabetes | 42 (18.8) | 16 (14.0) | 0.290 | 41 (19.2) | 16 (14.4) | 0.356 |
 Liver disease | 10 (4.5) | 1 (0.9) | 0.107 | 7 (3.3) | 0 (0) | 0.100 |
 Renal disease | 5 (2.2) | 1 (0.9) | 0.668 | 5 (2.3) | 0 (0) | 0.169 |
 Hemi- or paraplesia | 1 (0.4) | 0 (0) | 0.474 | 1 (0.5) | 0 (0) | 0.470 |
 Rheumatologic disorder | 2 (0.9) | 0 (0) | 0.551 | 2 (0.9) | 0 (0) | 0.548 |
 Any malignancies | 4 (1.8) | 2 (1.8) | 0.979 | 3 (1.4) | 1 (0.9) | 0.695 |
Charlson comorbidity index | ||||||
 Median [range] | 1.0 [0–5] | 0 [0–3] | 0.104 | 1.0 [0–5] | 0 [0–3] | 0.118 |
 0 | 99 (44.4) | 60 (52.6) | 0.259 | 95 (44.6) | 58 (52.3) | 0.266 |
 1–2 | 107 (48.0) | 49 (43.0) |  | 103 (48.4) | 49 (44.1) |  |
  ≥ 3 | 17 (7.6) | 5 (4.4) |  | 15 (7.0) | 4 (3.6) |  |
Combined resection | Â | Â | 0.295 | Â | Â | 0.574 |
 None | 195 (87.4) | 106 (93.0) |  | 192 (90.1) | 103 (92.8) |  |
 Gallbladder | 25 (11.2) | 7 (6.1) |  | 21 (9.4) | 7 (6.3) |  |
 Spleen | 3 (1.3) | 1 (0.9) |  | 1 (0.5) | 1 (0.9) |  |
Tumor size (mm) | 3.4 ± 1.8 | 3.2 ± 1.9 | 0.497 | 3.3 ± 1.7 | 3.2 ± 1.9 | 0.595 |
Proximal resected margin (cm) | 2.6 ± 2.2 | 2.7 ± 2.3 | 0.799 | 2.6 ± 2.2 | 2.7 ± 2.4 | 0.702 |
Mean retrieved lymph nodes | 46.2 ± 18.7 | 47.2 ± 15.8 | 0.603 | 46.8 ± 18.6 | 47.2 ± 15.6 | 0.827 |
Number of metastatic lymph nodes | 0.8 ± 2.3 | 0.6 ± 2.5 | 0.578 | 0.7 ± 2.2 | 0.6 ± 2.5 | 0.880 |
R0 resection | 223 (100) | 114 (100) | – | 213 (100) | 111 (100) | – |
Number of patients transfused | 2 (0.9) | 1 (0.9) | 0.985 | 1 (0.5) | 1 (0.9) | 0.638 |
Operation time (minutes) | 267.3 ± 50.3 | 277.6 ± 60.5 | 0.118 | 266.1 ± 49.5 | 278.5 ± 61.0 | 0.066 |
Hospital stay | 11.9 ± 8.0 | 10.9 ± 6.9 | 0.216 | 11.8 ± 6.7 | 10.8 ± 6.7 | 0.222 |
pT category | Â | Â | 0.201 | Â | Â | 0.274 |
 pT1 | 146 (65.5) | 85 (74.6) |  | 144 (67.6) | 82 (73.9) |  |
 pT2 | 44 (19.7) | 15 (13.2) |  | 41 (19.2) | 15 (13.5) |  |
 pT3 | 25 (11.2) | 8 (7.0) |  | 22 (10.3) | 8 (7.2) |  |
 pT4 | 8 (3.6) | 6 (5.3) |  | 6 (2.8) | 6 (5.4) |  |
pN category | Â | Â | 0.250 | Â | Â | 0.413 |
 pN0 | 177 (79.4) | 99 (86.8) |  | 171 (81.2) | 96 (86.5) |  |
 pN1 | 22 (9.9) | 6 (5.3) |  | 20 (9.4) | 6 (5.4) |  |
 pN2 | 18 (8.1) | 5 (4.4) |  | 15 (7.0) | 5 (4.5) |  |
 pN3 | 6 (2.7) | 4 (3.5) |  | 5 (2.3) | 4 (3.6) |  |
TNM stagea | Â | Â | 0.497 | Â | Â | 0.741 |
 Stage I | 174 (78.0) | 95 (83.3) |  | 169 (79.3) | 92 (82.9) |  |
 Stage II | 29 (13.0) | 12 (10.5) |  | 27 (12.7) | 12 (10.8) |  |
 Stage III | 20 (9.0) | 7 (6.1) |  | 17 (8.0) | 7 (6.3) |  |
 Stage IV | 0 (0) | 0 (0) |  | 0 (0) | 0 (0) |  |
Adjuvant chemotherapy | 36 (16.1) | 17 (14.9) | 0.875 | 34 (16.0) | 17 (15.3) | 0.879 |